buflomedil sold brand name loftyl vasoactive drug used treat claudication symptoms peripheral arterial disease currently approved food drug administration fda use united states drug suspended marketing european union concerns severe neurological cardiac press release dated november ema suggested doctors stop using buflomedil consider alternative treatment options european commission advised member states revoke marketing various adverse effects reported acylation occurs chlorobenzene solvent presence gaseous hydrochloric acid give bufomedil demonstration hoesch reaction drug article relating cardiovascular system stub help wikipedia expanding httpsenwikipediaorgwikibuflomedil